UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A double-blind, randomized, multicenter, controlled study to evaluate the immunogenicity, safety, and tolerability of varicella vaccine (VARIVAX™) passage extension 34 (PE34) process administered concomitantly with measles, mumps, and rubella vaccine (M-M-R™ II)

Human vaccines & immunotherapeutics, 2020-11, Vol.16 (11), p.2634-2640

2020

Volltextzugriff (PDF)

Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants

Vaccine, 2017-06, Vol.35 (28), p.3564-3574

2017

Volltextzugriff (PDF)

Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: Results of an open-label, randomized, phase 3b controlled study in healthy infants

Vaccine, 2014-02, Vol.32 (8), p.965-972

2014

Volltextzugriff (PDF)

Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study

Journal of the Pediatric Infectious Diseases Society, 2020-04, Vol.9 (2), p.194-201

2020

Volltextzugriff (PDF)

Coadministration of RIX4414 oral human rotavirus vaccine does not impact the immune response to antigens contained in routine infant vaccines in the United States

Pediatrics (Evanston), 2008-11, Vol.122 (5), p.e1062-e1066

2008

Volltextzugriff (PDF)

Safety and immunogenicity of an upper-range release titer measles-mumps-rubella vaccine in children vaccinated at 12 to 15 months of age: a phase III, randomized study

Human vaccines & immunotherapeutics, 2018-12, Vol.14 (12), p.2921-2931

2018

Volltextzugriff (PDF)

A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax

Pediatrics (Evanston), 2006-02, Vol.117 (2), p.265-272

2006

Volltextzugriff (PDF)

A Phase 3, Single-arm Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine in Healthy Children 15 Months Through <18 Years of Age

The Pediatric infectious disease journal, 2024-06, Vol.43 (6), p.574-581

2024

Volltextzugriff (PDF)

Hard tissue characteristics of patients with bimaxillary protrusion

SADJ (Houghton), 2023-06, Vol.78 (3), p.130-136

2023

Volltextzugriff (PDF)

Incidence of Respiratory Syncytial Virus Lower Respiratory Tract Infections During the First 2 Years of Life: A Prospective Study Across Diverse Global Settings

The Journal of infectious diseases, 2022-08, Vol.226 (3), p.374-385

2022

Volltextzugriff (PDF)

Concomitant administration of a liquid formulation of human rotavirus vaccine (porcine circovirus-free) with routine childhood vaccines in infants in the United States: Results from a phase 3, randomized trial

Vaccine, 2021-03, Vol.39 (10), p.1534-1543

2021

Volltextzugriff (PDF)

1385. Concomitant Administration of Liquid Porcine Circovirus-free Human Rotavirus Vaccine with Routine Pediatric Vaccines Does Not Impact Immune Responses in Infants: Results from a Phase 3, Randomized Trial in the United States

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S702-S703

2020

Volltextzugriff (PDF)

Plurality in Anaang Language

International Journal of Research and Innovation in Social Science, 2023, Vol.VII (XI), p.893-904

2023

Volltextzugriff (PDF)

Evaluation of Clinical Case Definitions for Respiratory Syncytial Virus Lower Respiratory Tract Infection in Young Children

Journal of the Pediatric Infectious Diseases Society, 2023-05, Vol.12 (5), p.273-281

2023

Volltextzugriff (PDF)

The 6 June 2020 Western U.S. Derecho

Silas, Thomas Peter

2024

Volltextzugriff (PDF)

The distribution of orofacial clefts at the medunsa oral health centre, cleft clinic

Journal of cleft lip palate and craniofacial anomalies, 2018-01, Vol.5 (1), p.20-27

2018

Volltextzugriff (PDF)

1506. Burden of Respiratory Syncytial Virus (RSV) and Other Lower Respiratory Tract Viral Infections During the First Two Years of Life: a Prospective Study

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S756-S756

2020

Volltextzugriff (PDF)

Randomized Controlled Trial of the Safety and Immunogenicity of Revaccination With Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) in Adults 10 Years After a Previous Dose

Journal of the Pediatric Infectious Diseases Society, 2019-05, Vol.8 (2), p.105-114

2019

Volltextzugriff (PDF)

2855. Respiratory Syncytial Virus Neutralizing Antibodies in Cord Blood and Serum from Infants up to 2 Years of Age in a Multinational Prospective Study

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S74-S75

2019

Volltextzugriff (PDF)

Safety of cetirizine in infants 6 to 11 months of age: A randomized, double-blind, placebo-controlled study

Journal of Allergy and Clinical Immunology, 2003-06, Vol.111 (6), p.1244-1248

2003

Volltextzugriff (PDF)

Language, Proverbs, Power and Male Chauvinism in Anaang Society

Current Issues in Descriptive Linguistics and Digital Humanities, 2022, p.211-223

2022

Volltextzugriff (PDF)

A Randomized, Consistency Study Comparing Immunogenicity and Safety of 2 Vaccines Against Measles, Mumps and Rubella (MMR) Administered to Children 12–15 Months of Age

Open forum infectious diseases, 2016-12, Vol.3 (suppl_1)

2016

Volltextzugriff (PDF)

A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age

Human vaccines & immunotherapeutics, 2013-09, Vol.9 (9), p.1978-1988

2013

Volltextzugriff (PDF)

EFFECTS OF FISCAL DECENTRALIZATION ON POVERTY REDUCTION IN KENYA

International Journal for Innovation Education and Research, 2018-01, Vol.6 (1), p.213-230

2018

Volltextzugriff (PDF)

1 – 25 von 244

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(161)
Mit Volltextzugriff
(200)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

A double-blind, randomized, multicenter, controlled study to evaluate the immunogenicity, safety, and tolerability of varicella vaccine (VARIVAX™) passage extension 34 (PE34) process administered concomitantly with measles, mumps, and rubella vaccine (M-M-R™ II)

Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants

Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: Results of an open-label, randomized, phase 3b controlled study in healthy infants

Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study

Coadministration of RIX4414 oral human rotavirus vaccine does not impact the immune response to antigens contained in routine infant vaccines in the United States

Safety and immunogenicity of an upper-range release titer measles-mumps-rubella vaccine in children vaccinated at 12 to 15 months of age: a phase III, randomized study

A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax

A Phase 3, Single-arm Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine in Healthy Children 15 Months Through <18 Years of Age

Hard tissue characteristics of patients with bimaxillary protrusion

Incidence of Respiratory Syncytial Virus Lower Respiratory Tract Infections During the First 2 Years of Life: A Prospective Study Across Diverse Global Settings

Population Attributable Risk of Wheeze in 2–<6-Year-old Children, Following a Respiratory Syncytial Virus Lower Respiratory Tract Infection in The First 2 Years of Life

Concomitant administration of a liquid formulation of human rotavirus vaccine (porcine circovirus-free) with routine childhood vaccines in infants in the United States: Results from a phase 3, randomized trial

1385. Concomitant Administration of Liquid Porcine Circovirus-free Human Rotavirus Vaccine with Routine Pediatric Vaccines Does Not Impact Immune Responses in Infants: Results from a Phase 3, Randomized Trial in the United States

Plurality in Anaang Language

Evaluation of Clinical Case Definitions for Respiratory Syncytial Virus Lower Respiratory Tract Infection in Young Children

The 6 June 2020 Western U.S. Derecho

The distribution of orofacial clefts at the medunsa oral health centre, cleft clinic

1506. Burden of Respiratory Syncytial Virus (RSV) and Other Lower Respiratory Tract Viral Infections During the First Two Years of Life: a Prospective Study

Randomized Controlled Trial of the Safety and Immunogenicity of Revaccination With Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) in Adults 10 Years After a Previous Dose

2855. Respiratory Syncytial Virus Neutralizing Antibodies in Cord Blood and Serum from Infants up to 2 Years of Age in a Multinational Prospective Study

Safety of cetirizine in infants 6 to 11 months of age: A randomized, double-blind, placebo-controlled study

Language, Proverbs, Power and Male Chauvinism in Anaang Society

A Randomized, Consistency Study Comparing Immunogenicity and Safety of 2 Vaccines Against Measles, Mumps and Rubella (MMR) Administered to Children 12–15 Months of Age

A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age

EFFECTS OF FISCAL DECENTRALIZATION ON POVERTY REDUCTION IN KENYA

Suchergebnisse filtern